Easywell Biomedicals, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 359.960 million compared to TWD 419.178 million a year ago. Operating loss was TWD 215.972 million compared to TWD 192.627 million a year ago. Net loss was TWD 271.797 million compared to TWD 242.163 million a year ago. Basic loss per share from continuing operations was TWD 2.34 compared to TWD 1.75 a year ago. Basic loss per share was TWD 2.48 compared to TWD 2.45 a year ago.